DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /PyrrolesPyrroles
  6. /Glucocorticoid receptor agonist-4 Ala-Ala-MalCAS 3014393-37-1
Chemical structure of CAS 3014393-37-1

Glucocorticoid receptor agonist-4 Ala-Ala-Mal

CAS No.3014393-37-1
MDL No.N/A
MFC49H55FN4O12
MW911.00
InChI KeyBISHTACTVXELTJ-LXQRTRQESA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.3014393-37-1
Product NameGlucocorticoid receptor agonist-4 Ala-Ala-Mal
Heavy Atom Count66Rotatable Bond Count14
Atom Stereo Count11Bond Stereo Count0
HBA12HBD5
TPSA226.970 ŲCharge0
Exact Mass910.38005Complexity2469.70
pKa7.130XLogP3.579

Documentation

Similar Products

  • Glucocorticoid receptor agonist-1-Gly-Glu-Gly

    CAS No.2913230-74-5

  • DBCO-|A-Glu-PEG12-Exatecan

    CAS No.3025107-83-6

  • JF526-Taxol (TFA)

    CAS No.2410613-93-1

  • Glucocorticoid receptor agonist-1

    CAS No.2166375-82-0

  • Brigimadlin

    CAS No.2095116-40-6

  • Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-((2R,4R,6S,8S)-4-(1,1-difluoroethyl)-1,3,4,5,6,7,8,9-octahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12R,19alpha)-

    CAS No.162652-95-1

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact